Sanae Endo is a seasoned HR executive and a recognized leader in promoting wellness, women’s empowerment, and diversity & inclusion (D&I) across multiple industries. With a strong belief in the vital connection between employee well-being and organizational performance, she has spearheaded transformative initiatives that foster both psychological safety and physical health in the workplace.
Over the course of her career, she has designed and implemented pioneering programs such as Women in Leadership (WIL) and Parents@GAP, resulting in more than 40% representation of women in leadership roles. These efforts have significantly shifted corporate culture toward greater inclusivity, balance, and health consciousness.
As Chair of the D&I Governance Committee, Ms. Endo established Employee Resource Groups (ERGs) and built inclusive frameworks to support diverse talent, ensuring that all employees feel safe, respected, and empowered. She has also led internal wellness strategies that incorporate mental health support, flexible work policies, and holistic well-being as core drivers of organizational success.
As the first female executive officer in her organization, has been providing a pivotal role in promoting family support programs, People with Disability Support and inclusive policy reforms.
Ms. Endo holds certifications in Six Sigma, Hogan Assessment, professional coaching, and vocational counseling for persons with disabilities. She serves as a board member of the Kids & Family Association to promote wheelchair basketball, and has contributed as an external advisor to the Cartier Women’s Initiative.

Dr. Takayuki Okada is a cardiovascular surgeon actively engaged in clinical practice, education, and research both in Japan and internationally.
After graduating from Kansai Medical University, he has developed deep expertise in valvular heart surgery, aortic surgery, and coronary artery surgery. His research interests include vascular endothelial regeneration in coronary artery bypass grafting, advancement of surgical techniques in aortic surgery, and the management of heritable cardiovascular diseases, particularly Marfan syndrome.
Dr. Okada has gained valuable international experience through fellowships at the National Heart Institute (IJN), Malaysia, and the Department of Cardiac Surgery, Heidelberg University, Germany, fostering strong ties in medical technology exchange across Asia and Europe.
He is also dedicated to medical education, mentoring young physicians and medical students both in Japan and internationally. Dr. Okada actively promotes medical education exchange and global human resource development, with a focus on collaborations with countries in Asia and Africa.
Since April 2025, he serves as Associate Professor and Head of Cardiovascular Surgery at Kansai Medical University Medical Center. He continues to lead in clinical excellence while expanding his contributions to international medical cooperation and educational partnerships.

Silas Habimana is a multidisciplinary scientist with a strong foundation in molecular biotechnology and chemical engineering. He earned a Bachelor of Science in Molecular Biotechnology from the University of Arkansas at Little Rock in 2013 and went on to complete a Master of Engineering in Chemical Engineering at Kyushu University, Japan, in 2023. Silas has been recognized for his academic excellence the Rwanda Presidential Scholarship and multiple MEXT (Monbukagakusho) Scholarships from the Government of Japan. He received the Excellent Research Presentation Award from the Society of Chemical Engineers, Japan, in 2023, and served as a keynote speaker at Droplet2024 hosted by On-chip Biotechnologies.
Throughout his career, Silas has gained international experience across research and laboratory environments in the United States, Rwanda, and Japan. He began his professional journey as a Laboratory Technician in molecular diagnostics at BioMedNanoTech Inc. in Arkansas, followed by roles in molecular hematology at INES-Ruhengeri and DNA profiling for human identification at Scientific Innovations Ltd. in Rwanda. His cross-sectoral experience and deep technical expertise position him at the forefront of biotechnological innovation, where he continues to explore impactful solutions for health, science, and society.

Dr. Menelas Nkeshimana is a Senior Consultant Physician and Head of Health Workforce Development at the Ministry of Health Rwanda, where he leads the implementation of the 4x4 Health Workforce Reform, a national initiative to quadruple the health workforce by 2028. He holds an MBBS (Hons.), an MMED in Internal Medicine, and an MSc in Global Health Delivery from the University of Global Health Equity, bringing extensive expertise in clinical care, public health leadership, and medical education.
Previously, Dr. Nkeshimana served as Head of Emergency Medicine at one of Rwanda’s largest public and academic hospitals and is an Honorary Senior Lecturer at the University of Rwanda. He played a key role in the clinical management of the COVID-19 pandemic and other regional epidemics. He also co-leads several globally funded research initiatives, including NIH-funded projects, focused on emergency care and health systems strengthening. His work champions high-impact, cost-effective innovations grounded in the realities of frontline health systems, with a global health perspective.

Manuel Martín Lozano is an advisor working with the Rwanda Development Board, where he focuses on private sector development, particularly in the pharmaceutical and medical tourism industries. Before his work in Rwanda, Manuel advised governments in the Middle East on the design of national economic strategies and initiatives to promote private sector growth. He also has experience working with private equity firms and financial institutions. Manuel holds degrees in Economics and Law from the University of Navarra.